Skip to main content
. 2011 Jun 1;26(2):153–159. doi: 10.3904/kjim.2011.26.2.153

Table 2.

Treatment modalities and adverse reactions among patients who had multidrug-resistant tuberculosis (MDR-TB) treated with levofloxacin or moxifloxacin

graphic file with name kjim-26-153-i002.jpg

Values are presented as number (%). p values were based on a comparison between patients on levofloxacin and patients on moxifloxacin.

IQR, interquartile range.